Used primarily as an intermediate in the synthesis of proton pump inhibitors (PPIs), this compound plays a key role in the development of medications that reduce stomach acid production. It is involved in the preparation of anti-ulcer drugs, particularly those used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related gastrointestinal disorders. Due to its structural features, it enables selective inhibition of the H+/K+ ATPase enzyme system in the gastric parietal cells, making it valuable in pharmaceutical manufacturing. Its derivatives are known for high potency and prolonged duration of action, contributing to once-daily dosing formulations in modern acid-suppressive therapy.